Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism

The aim of the present study was to evaluate the protective effect and mechanism of Astragaloside IV (ASIV) on myocardial injury induced by type 2 diabetes, with a focus on energy metabolism. Blood glucose, the hemodynamic index, left ventricular weight/heart weight (LVW/HW), the left ventricular sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhen, Wang, Jing, Zhu, Yingwei, Zhang, Hui, Wang, Hongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797977/
https://www.ncbi.nlm.nih.gov/pubmed/31702040
http://dx.doi.org/10.3892/mmr.2019.10716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797977/
https://www.ncbi.nlm.nih.gov/pubmed/31702040
http://dx.doi.org/10.3892/mmr.2019.10716

Ejemplares similares